Price $75.76 |
Market Cap
14.5B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.73
|
P/S
9.14
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
20.2K
|
FCF
-0.7
|
|
Op. Margin
-8.10%
|
Net Margin
-5.10%
|
ROE
-2.60%
|
ROI
-1.50%
|
|
ROA
-1.70%
|
EPS Growth
47.10%
|
Current Ratio
3.9
|
Debt/Equity
28.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| US NeuroSurgical Holdings Inc (USNU) | $0.23 | - | - | 1.5M | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLN) | $0.66 | - | - | 12.8M | Strong Buy |
| Champions Oncology Inc (CSBR) | $5.95 | - | - | 76.8M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.27 | - | - | 12.3M | Strong Buy |
| Cocrystal Pharma Inc (COCP) | $2.45 | - | - | 72.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
